Home based Augmented Reality Platform for Efficient Rehabilitation of stroke patients

Información del proyecto

HARPER

Identificador del acuerdo de subvención: 868369

DOI

10.3030/868369

Proyecto cerrado

Fecha de la firma de la CE 13 Mayo 2019

Fecha de inicio 1 Junio 2019

Fecha de finalización 31 Octubre 2019

Financiado con arreglo a

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

BRAIN STIMULATION AB
Sweden

Periodic Reporting for period 1 - HARPER (Home based Augmented Reality Platform for Efficient Rehabilitation of stroke patients)

Período documentado: 2019-06-01 hasta 2019-10-31

Resumen del contexto y de los objetivos generales del proyecto

Challenge: Rehabilitating patients with cognitive and upper limb problems from Stroke. Cognitive impairments as in the Neglect Syndrome is not discovered nor treated in suitable time and the normal hospital stay is too short to rehabilitate the patients properly. If the Neglect Syndrome is discovered and treated faster and better than today, the wellbeing of patients will increase. The burden and the costs for their care will be significantly reduced. Around 30% of the 16 Million new stroke patients worldwide per year suffer from the Neglect Syndrome i.e. there are 5-6 million new patients per year.

The long-term goal of this project is to create a successful market introduction and growth path for Brain Stimulation’s innovation.

The conclusion of the phase 1 project is that we have technical, economic and practical feasibility to continue our innovation process.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

We have prepared our Concept for Stroke Home Rehabilitation, test and proof of concept evaluation. RehAtt®-VR has been transferred to the new technical platform HoloLens from Microsoft. A pilot-study have been performed with five volunteers as part of a first Proof of Concept evaluation. The validated VR-DiSTRO® (test-battery) has been used in comparison to the use of conventional Neglect Syndrome tests. Normative diagnostics data have been collected. Potential health economical gains have been identified. A competitor analysis has been done. We have mapped and prioritized potential users, segments and markets. We have elaborated a qualified IPR portfolio strategy including branding of the innovation, freedom to operate and regulatory strategy for Home Rehabilitation. We have made a strategic evaluation of subcontractors and knowledge partners We have made a financial strategy. We have update our business innovation plan.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

There’s a great interest from leading scientists and Key Opinion Leaders within stroke care. We are likely to add and increase the scale of studies and scientific cooperation’s beyond our expectations. We are likely to find greater line extensions and scientific spin-offs using our know-how and technology. The over-all market potential, impact and Health Economic benefits exceed our initial expectations. The next generation of hardware HoloLens 2 will improve and add new features with increased usability and possibilities. The Market direction is towards e-health and digitalization, homecare and mobile health teams fit our value proposition very good and timing seems correct.

image002.png